GnRH-agonist ovulation trigger in patients undergoing controlled ovarian hyperstimulation for IVF with ultrashort flare GnRH-agonist combined with multidose GnRH-antagonist protocol

Gynecological Endocrinology

Volumn 29, Issue 1, 2013, Pages 51-53

  Orvieto, Raoul ^a,b   Nahum, Ravit ^a,b   Zohav, Efraim ^a,b   Liberty, Gad ^a   Anteby, Eyal Y ^a,b   Meltcer, Simion ^a  

^a BARZILAI MEDICAL CENTER   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

COH; GnRH agonist; IVF outcome; Multidose GnRH antagonist; Ovulation trigger; Ultrashort GnRH agonist

Indexed keywords

CETRORELIX; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; TRIPTORELIN;

ADULT; CLINICAL ARTICLE; CONTROLLED STUDY; EMBRYO TRANSFER; FEMALE; FERTILIZATION; FERTILIZATION IN VITRO; HUMAN; OOCYTE MATURATION; OUTCOME ASSESSMENT; OVARY HYPERSTIMULATION; OVULATION; PREGNANCY RATE; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

ADULT; COHORT STUDIES; DATABASES, FACTUAL; FEMALE; FERTILIZATION; FERTILIZATION IN VITRO; GONADOTROPIN-RELEASING HORMONE; GONADOTROPINS; HUMANS; INFERTILITY, FEMALE; LUTEOLYTIC AGENTS; OOCYTES; OVARIAN HYPERSTIMULATION SYNDROME; OVULATION; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; RISK FACTORS; TRIPTORELIN PAMOATE;

EID: 84870492219     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2012.705376     Document Type: Review

References (11)

1. Penzias AS. Improving results with assisted reproductive technologies: individualized patient-tailored strategies for ovulation induction. Reprod Biomed Online 2004;9:43-46.
2. Killick SR. Ultrasound and the receptivity of the endometrium. Reprod Biomed Online 2007;15:63-67.
3. The Practice Committee of the American Society for Reproductive Medicine (ASRM). Ovarian hyperstimulation syndrome. Fertil Steril 2008;90:S188-93.
4. Kol S. Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome. Fertil Steril 2004;81:1-5.
5. Orvieto R. Can we eliminate severe ovarian hyperstimulation syndrome? Hum Reprod 2005;20:320-322.
6. Orvieto R, Kruchkovich J, Rabinson J, Zohav E, Anteby EY, Meltcer S. Ultrashort gonadotropin-releasing hormone agonist combined with flexible multidose gonadotropin-releasing hormone antagonist for poor responders in in vitro fertilization/embryo transfer programs. Fertil Steril 2008;90:228-230.
7. Orvieto R, Nahum R, Rabinson J, Gemer O, Anteby EY, Meltcer S. Ultrashort flare GnRH agonist combined with flexible multidose GnRH antagonist for patients with repeated IVF failures and poor embryo quality. Fertil Steril 2009;91:S1398-400.
8. Orvieto R, Meltcer S, Liberty G, Rabinson J, Anteby EY, Nahum R. A combined approach to patients with repeated IVF failures. Fertil Steril 2010;94:2462-2464.
9. Keltz MD, Gera PS, Skorupski J, Stein DE. Comparison of FSH flare with and without pretreatment with oral contraceptive pills in poor responders undergoing in vitro fertilization. Fertil Steril 2007;88:350-353.
10. Surrey ES, Bower J, Hill DM, Ramsey J, Surrey MW. Clinical and endocrine effects of a microdose GnRH agonist flare regimen administered to poor responders who are undergoing in vitro fertilization. Fertil Steril 1998;69:419-424.
11. Takahashi K, Mukaida T, Tomiyama T, Goto T, Oka C. GnRH antagonist improved blastocyst quality and pregnancy outcome after multiple failures of IVF/ICSI-ET with a GnRH agonist protocol. J Assist Reprod Genet 2004;21:317-322.